Company record
Park Avenue Compounding
0 FDA warning letters since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about Park Avenue Compounding.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Dec 10, 2025 | Class II | Park Avenue Compounding Drug |
Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1. CGMP Deviations FDA notice D-0200-2026 |
| Nov 26, 2025 | Class II | Park Avenue Compounding Drug |
Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1. CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results. FDA notice D-0178-2026 |